RE: Big buying28 Jul 2023 10:27
I'm 95% sure this rise (let's be honest, a penny or two is insignificant for LTHs on not really a rise at all!) has nothing concrete behind it and we'll continue to hover around this level or maybe drop back again for some months yet.
But you also can never completely rule something out. STRIVE and PTs were not ruled out by Simon Shaw. He just said that they'd not heard anything from them and decided, correctly IMO, to crack on with their own plans. But he was clear that if, for example, STRIVE became an option, then they would hand over the required amounts of drug and let them crack on with it. I mean why wouldn't you?
So for me it's a very outside chance, but it still is possible. And maybe the fact these PTs and STRIVE are so glacially slow has made us complacent and written it off when we shouldn't have. I maintain that we were on of the few candidates passed through ACTIV-2 P2, the NIH have already spent a lot of money on us and what we offer is potentially something quite different. I think they'd be mad not to give us another shot. But that's just IMO.